NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 10 10:21AM ET
25.85
Dollar change
+0.07
Percentage change
0.29
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y-4.55% Total Holdings50 Perf Week2.47%
SponsorTema ETF Type Tagsequity Return% 3Y- AUM72.15M Perf Month1.91%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter23.23%
Index- Average Maturity Tags- Return% 10Y 52W High29.85 -13.40% Perf Half Y4.17%
Index Weighting Commodity Type Tags- Return% SI 52W Low20.10 28.66% Perf YTD6.36%
Active/Passive Quant Type Tags- Flows% 1M-2.06% Volatility3.55% 2.31% Perf Year-4.39%
Dividend TTM0.50 (1.93%) ESG Type Tags- Flows% 3M3.36% ATR (14)0.65 Perf 3Y-
Dividend Ex-DateDec 11, 2024 Dividend Type Sector/Theme Flows% YTD41.29% RSI (14)59.80 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.97 Perf 10Y-
Expense0.75% Growth/Value SMA202.63% Flows% 3Y Rel Volume0.79 Prev Close25.78
Inverse/Leveraged Market Cap SMA505.13% Flows% 5Y Avg Volume17.96K Price25.85
IPOAug 16, 2023 Option/ShortNo / Yes SMA2001.42% Trades Volume3,663 Change0.29%
Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.